A Randomized, Double-blind, Placebo-controlled Trial of Golimumab+Methotrexate Versus Methotrexate Alone in Methotrexate-naive Patients With Psoriatic Arthritis

Trial Profile

A Randomized, Double-blind, Placebo-controlled Trial of Golimumab+Methotrexate Versus Methotrexate Alone in Methotrexate-naive Patients With Psoriatic Arthritis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Golimumab (Primary) ; Folic acid; Methotrexate
  • Indications Psoriatic arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 29 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2012-005214-19).
    • 25 Jun 2013 New trial record
    • 20 Jun 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top